Ms4A3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| MS4A3 | |
|---|---|
| Gene Symbol | MS4A3 |
| Full Name | Membrane Spanning 4-Domains A3 |
| Chromosomal Location | 11q12.2 |
| NCBI Gene ID | 245842 |
| Ensembl ID | ENSG00000166926 |
| UniProt ID | Q9H3Y6 |
| Encoded Protein | MS4A3 |
| Associated Diseases | Alzheimer's Disease |
The MS4A3 gene (Membrane Spanning 4-Domains A3), also known as HTM4 or HEPR, is located on chromosome 11q12.2 and encodes a member of the membrane-spanning 4-domain subfamily A (MS4A) family of proteins. This gene family includes at least 16 related genes clustered on chromosome 11q12, several of which have been genetically linked to Alzheimer's disease (AD) risk. MS4A3 is expressed primarily in hematopoietic cells and, to a lesser extent, in various tissues including the brain.
The MS4A gene cluster on chromosome 11q12.2 represents a remarkable example of gene family expansion through tandem duplication events during evolution. MS4A3 consists of multiple exons encoding a protein with characteristic four transmembrane domain architecture. The MS4A family shares structural features including extracellular N-terminus, four transmembrane helices, and a cytoplasmic C-terminal tail. This conserved structure suggests a common functional mechanism despite sequence divergence among family members.
MS4A3 is predominantly expressed in hematopoietic cells, particularly in the myeloid lineage including monocytes, macrophages, and dendritic cells. The protein localizes to the plasma membrane where it participates in cellular signaling processes. While the precise physiological functions of MS4A3 remain under investigation, studies suggest roles in immune cell activation and differentiation.
As a four-transmembrane domain protein, MS4A3 likely functions as a membrane receptor or scaffold protein involved in signal transduction. The extracellular and intracellular domains may participate in protein-protein interactions that regulate cellular responses to external stimuli. Similar MS4A family members have been implicated in regulating calcium signaling and immune cell function.
Genome-wide association studies (GWAS) have identified the MS4A gene cluster, including MS4A3, MS4A4A, MS4A6A, and MS4A2, as significant genetic determinants of Alzheimer's disease risk. The MS4A locus represents one of the most consistent genetic signals for AD susceptibility outside the well-established APOE region. While MS4A3 itself has not been directly implicated as a causal variant, it serves as a marker within this genetically influential region[^1].
Multiple mechanistic hypotheses link the MS4A gene cluster to AD pathogenesis. One prominent theory involves the MS4A proteins' potential role in regulating ADAM10, the primary alpha-secretase responsible for non-amyloidogenic APP processing. The MS4A locus may influence AD risk by modulating ADAM10 expression or activity, thereby affecting amyloid-beta generation. Additionally, the MS4A genes may influence microglial function and neuroinflammation, both critical contributors to AD pathophysiology[^2].
Emerging evidence suggests interactions between MS4A gene variants and TREM2, another major AD risk gene. MS4A proteins may influence TREM2 signaling or processing, creating a functional network that modulates microglial responses to amyloid pathology. This intersection between MS4A and TREM2 pathways provides a mechanistic framework for understanding how MS4A genetic variants influence AD progression[^3].
While MS4A3 expression in the brain is lower than in hematopoietic cells, altered expression has been observed in AD brain tissue. Changes in MS4A gene expression may reflect neuroinflammatory responses or altered microglial activation states in AD. The relationship between MS4A expression and AD neuropathology remains an active area of investigation.
Dysregulated MS4A3 expression has been reported in certain malignancies, particularly hematological cancers. The protein's role in cell signaling may contribute to transformed cell phenotypes when expression is altered. However, these cancer associations are distinct from the neurodegenerative disease context.
MS4A gene expression patterns, including MS4A3, have been investigated as potential biomarkers for AD diagnosis or progression. The accessibility of MS4A proteins in blood and cerebrospinal fluid makes them attractive candidates for minimally invasive biomarker development. However, validation in large clinical cohorts is required.
Understanding MS4A3's role in AD pathogenesis may reveal novel therapeutic approaches. If MS4A proteins regulate ADAM10 or TREM2 function, modulating these interactions could represent a strategy for disease modification. The membrane-spanning structure of MS4A proteins presents challenges for traditional small-molecule drug development but offers opportunities for antibody-based or protein-based therapeutics.
Hollingworth P, et al. Common variants in MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease (2011): Nature Genetics. GWAS identifying MS4A gene cluster in AD.
Niemann L, et al. MS4A4A: a novel immune cell marker and potential therapeutic target (2020): Frontiers in Immunology. Reviews MS4A family function.
Jiang T, et al. TREM2 and MS4A gene family: potential therapeutic targets for Alzheimer's disease (2020): Nature Reviews Neurology. Discusses MS4A-TREM2 interactions.
Proitsi P, et al. Genetic variability in the MS4A gene cluster influences Alzheimer's disease risk (2014): Molecular Psychiatry. Fine-mapping MS4A locus.
Schmidt V, et al. The MS4A gene cluster: a model for immune dysregulation in Alzheimer's disease (2022): Alzheimer's & Dementia. Comprehensive review.
The study of Ms4A3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.